Document Detail

Two cases of idiopathic localized involutional lipoatrophy.
MedLine Citation:
PMID:  20711277     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Localized involutional lipoatrophy (LIL) is a rare distinctive idiopathic form of localized lipoatrophy. The characteristic features in histopathology of LIL are diminutive fat lobules composed of small adipocyte resembling fetal fat tissue. LIL is not a well-known disorder, there have been only a few reports on LIL in the English literature. We herein report 2 cases of LIL and review the previously published cases.
Young Bok Lee; Jung Eun Kim; Hyun Jeong Park; Baik Kee Cho
Related Documents :
2790767 - Is trisomy 22 in acute myeloid leukemia a primary abnormality or only a secondary chang...
21323097 - Cyclosporine for sjs/ten: a case series and review of the literature.
16472857 - Gain of 1q in pediatric myelodysplastic syndromes.
1525097 - Clinical and histopathological features of parvovirus b19 infection in the human fetus.
19319547 - Prenatal diagnosis of thoracopagus fetus: a case report with brief review of literature.
10855157 - Case management: a case study.
Publication Detail:
Type:  Journal Article     Date:  2010-08-05
Journal Detail:
Title:  Annals of dermatology     Volume:  22     ISSN:  2005-3894     ISO Abbreviation:  Ann Dermatol     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-08-16     Completed Date:  2011-07-14     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  8916577     Medline TA:  Ann Dermatol     Country:  Korea (South)    
Other Details:
Languages:  eng     Pagination:  346-8     Citation Subset:  -    
Department of Dermatology, St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Three cases of primary inoculation tuberculosis as a result of illegal acupuncture.
Next Document:  Recalcitrant atopic dermatitis treated with omalizumab.